Evaluation of Retinoid Lactones as Topical Therapeutic Agents in Dermatology View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-07

AUTHORS

Anita H. Lewin, Sherry L. Black, Mary E. Bos, R. Richard Goehring, Xina Nair, Gary Whiting, Pamela Bouquin, Geraldine Tetrault, F. Ivy Carroll

ABSTRACT

Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis,13-cis-12-hydroxymethylretinoic acid, δ-lactone (1) relative to antihyperproliferation and antihyperkeratinization vs. toxicity.Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation.Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1.Conclusions. The δ-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an anti-hyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne. More... »

PAGES

983-992

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1016250129246

DOI

http://dx.doi.org/10.1023/a:1016250129246

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052617200

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7494818


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Topical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Evaluation, Preclinical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Keratins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tretinoin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lewin", 
        "givenName": "Anita H.", 
        "id": "sg:person.0615103145.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615103145.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Black", 
        "givenName": "Sherry L.", 
        "id": "sg:person.011330011677.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011330011677.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bos", 
        "givenName": "Mary E.", 
        "id": "sg:person.01354063200.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354063200.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goehring", 
        "givenName": "R. Richard", 
        "id": "sg:person.0634600476.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634600476.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nair", 
        "givenName": "Xina", 
        "id": "sg:person.01246547754.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246547754.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whiting", 
        "givenName": "Gary", 
        "id": "sg:person.0753620654.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753620654.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bouquin", 
        "givenName": "Pamela", 
        "id": "sg:person.01330234261.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330234261.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tetrault", 
        "givenName": "Geraldine", 
        "id": "sg:person.01362776354.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362776354.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carroll", 
        "givenName": "F. Ivy", 
        "id": "sg:person.01007744060.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007744060.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1018938920796", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017325399", 
          "https://doi.org/10.1023/a:1018938920796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018955925223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012524380", 
          "https://doi.org/10.1023/a:1018955925223"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-07", 
    "datePublishedReg": "1995-07-01", 
    "description": "Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis,13-cis-12-hydroxymethylretinoic acid, \u03b4-lactone (1) relative to antihyperproliferation and antihyperkeratinization vs. toxicity.Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation.Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1.Conclusions. The \u03b4-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an anti-hyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1016250129246", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "therapeutic ratio", 
      "topical therapeutic agents", 
      "favorable therapeutic ratio", 
      "inhibition of TPA", 
      "topical treatment", 
      "retinoid toxicity", 
      "topical activity", 
      "systemic toxicity", 
      "therapeutic agents", 
      "skin irritation", 
      "unique molecular features", 
      "potent lactone", 
      "molecular features", 
      "DNA synthesis", 
      "toxicity", 
      "hyperkeratinization", 
      "acne", 
      "agents", 
      "irritation", 
      "dermatology", 
      "treatment", 
      "inhibition", 
      "TPA", 
      "analogues", 
      "ratio", 
      "absence", 
      "activity", 
      "evaluation", 
      "good candidate", 
      "cyclohexenyl moiety", 
      "use", 
      "candidates", 
      "acid", 
      "lactones", 
      "lactone 1", 
      "features", 
      "lactone ring", 
      "synthesis", 
      "view", 
      "variation", 
      "moiety", 
      "ring", 
      "optimization", 
      "antihyperproliferation", 
      "antihyperkeratinization", 
      "lipophilic cyclohexenyl moiety", 
      "more potent lactones", 
      "parent lactone 1", 
      "desirable therapeutic ratio", 
      "antihyperkeratotic agent", 
      "low systemic retinoid toxicity", 
      "systemic retinoid toxicity", 
      "Retinoid Lactones"
    ], 
    "name": "Evaluation of Retinoid Lactones as Topical Therapeutic Agents in Dermatology", 
    "pagination": "983-992", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052617200"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1016250129246"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7494818"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1016250129246", 
      "https://app.dimensions.ai/details/publication/pub.1052617200"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_266.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1016250129246"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1016250129246'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1016250129246'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1016250129246'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1016250129246'


 

This table displays all metadata directly associated to this object as RDF triples.

222 TRIPLES      22 PREDICATES      92 URIs      82 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1016250129246 schema:about N2817f4b38e21483c8db54ac822830e10
2 N318cfe29357049bf96a7b11b364de49e
3 N4c99cafbfb2a43c297d6c1d2457cd333
4 N69984b2d614d452086cee29ccebb4a6d
5 N8c052f0fc374402da0d7a284ac32154f
6 N96ea7d1b7a1f412ebcd42a038f5af9c8
7 Naf7cd6f5b2854aea81259d47cee36196
8 Ncf0d81d0e1434abe98446c67dbe22434
9 Nd755d7a47d8d4f448e5d49bd22a9495c
10 Nf684b89a05444351b8482cef2f1db84f
11 anzsrc-for:11
12 anzsrc-for:1115
13 schema:author Nc453e3459ffb4ed19627449bf7a598b7
14 schema:citation sg:pub.10.1023/a:1018938920796
15 sg:pub.10.1023/a:1018955925223
16 schema:datePublished 1995-07
17 schema:datePublishedReg 1995-07-01
18 schema:description Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis,13-cis-12-hydroxymethylretinoic acid, δ-lactone (1) relative to antihyperproliferation and antihyperkeratinization vs. toxicity.Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation.Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1.Conclusions. The δ-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an anti-hyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N4e2e72b8e0f54220a89d32609e20edb3
23 N6dfc208b4a914819b2731384551b7be3
24 sg:journal.1094644
25 schema:keywords DNA synthesis
26 Retinoid Lactones
27 TPA
28 absence
29 acid
30 acne
31 activity
32 agents
33 analogues
34 antihyperkeratinization
35 antihyperkeratotic agent
36 antihyperproliferation
37 candidates
38 cyclohexenyl moiety
39 dermatology
40 desirable therapeutic ratio
41 evaluation
42 favorable therapeutic ratio
43 features
44 good candidate
45 hyperkeratinization
46 inhibition
47 inhibition of TPA
48 irritation
49 lactone 1
50 lactone ring
51 lactones
52 lipophilic cyclohexenyl moiety
53 low systemic retinoid toxicity
54 moiety
55 molecular features
56 more potent lactones
57 optimization
58 parent lactone 1
59 potent lactone
60 ratio
61 retinoid toxicity
62 ring
63 skin irritation
64 synthesis
65 systemic retinoid toxicity
66 systemic toxicity
67 therapeutic agents
68 therapeutic ratio
69 topical activity
70 topical therapeutic agents
71 topical treatment
72 toxicity
73 treatment
74 unique molecular features
75 use
76 variation
77 view
78 schema:name Evaluation of Retinoid Lactones as Topical Therapeutic Agents in Dermatology
79 schema:pagination 983-992
80 schema:productId N08e75faa1d5f4ae6b51107ebe7e1fb7c
81 N7fd2c33e27d84f11bf79754508631dcb
82 N913b8560b27345a2ae0826a7c4c54ae0
83 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052617200
84 https://doi.org/10.1023/a:1016250129246
85 schema:sdDatePublished 2021-12-01T19:09
86 schema:sdLicense https://scigraph.springernature.com/explorer/license/
87 schema:sdPublisher Nb8dbefe2e577417d9ddb7508a54a3c17
88 schema:url https://doi.org/10.1023/a:1016250129246
89 sgo:license sg:explorer/license/
90 sgo:sdDataset articles
91 rdf:type schema:ScholarlyArticle
92 N01483064a72c419fb443956bb72f1ebc rdf:first sg:person.01007744060.52
93 rdf:rest rdf:nil
94 N08e75faa1d5f4ae6b51107ebe7e1fb7c schema:name pubmed_id
95 schema:value 7494818
96 rdf:type schema:PropertyValue
97 N1e154c4603ae4867bdcc0a8b9d7dd087 rdf:first sg:person.011330011677.32
98 rdf:rest N832268efe2e2452dbe368825c2c5ac74
99 N2817f4b38e21483c8db54ac822830e10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Retinoids
101 rdf:type schema:DefinedTerm
102 N318cfe29357049bf96a7b11b364de49e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Keratins
104 rdf:type schema:DefinedTerm
105 N4c99cafbfb2a43c297d6c1d2457cd333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Mice
107 rdf:type schema:DefinedTerm
108 N4e2e72b8e0f54220a89d32609e20edb3 schema:issueNumber 7
109 rdf:type schema:PublicationIssue
110 N69984b2d614d452086cee29ccebb4a6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Lactones
112 rdf:type schema:DefinedTerm
113 N6dfc208b4a914819b2731384551b7be3 schema:volumeNumber 12
114 rdf:type schema:PublicationVolume
115 N7fd2c33e27d84f11bf79754508631dcb schema:name dimensions_id
116 schema:value pub.1052617200
117 rdf:type schema:PropertyValue
118 N832268efe2e2452dbe368825c2c5ac74 rdf:first sg:person.01354063200.10
119 rdf:rest N8871e3feb7854970af2d661bc4533c7c
120 N8871e3feb7854970af2d661bc4533c7c rdf:first sg:person.0634600476.22
121 rdf:rest Nd0075afa2a6f4d0d9e4aa58b2055a40a
122 N8c052f0fc374402da0d7a284ac32154f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Skin Diseases
124 rdf:type schema:DefinedTerm
125 N912e112afb564393a7c58a38e07550b9 rdf:first sg:person.0753620654.00
126 rdf:rest Nc1dd7ac7b8614c0d925998f7ff675924
127 N913b8560b27345a2ae0826a7c4c54ae0 schema:name doi
128 schema:value 10.1023/a:1016250129246
129 rdf:type schema:PropertyValue
130 N96ea7d1b7a1f412ebcd42a038f5af9c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Skin
132 rdf:type schema:DefinedTerm
133 Nac7ee63029a54900ac52012d7b2974be rdf:first sg:person.01362776354.62
134 rdf:rest N01483064a72c419fb443956bb72f1ebc
135 Naf7cd6f5b2854aea81259d47cee36196 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Animals
137 rdf:type schema:DefinedTerm
138 Nb8dbefe2e577417d9ddb7508a54a3c17 schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 Nc1dd7ac7b8614c0d925998f7ff675924 rdf:first sg:person.01330234261.41
141 rdf:rest Nac7ee63029a54900ac52012d7b2974be
142 Nc453e3459ffb4ed19627449bf7a598b7 rdf:first sg:person.0615103145.58
143 rdf:rest N1e154c4603ae4867bdcc0a8b9d7dd087
144 Ncf0d81d0e1434abe98446c67dbe22434 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Administration, Topical
146 rdf:type schema:DefinedTerm
147 Nd0075afa2a6f4d0d9e4aa58b2055a40a rdf:first sg:person.01246547754.63
148 rdf:rest N912e112afb564393a7c58a38e07550b9
149 Nd755d7a47d8d4f448e5d49bd22a9495c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Drug Evaluation, Preclinical
151 rdf:type schema:DefinedTerm
152 Nf684b89a05444351b8482cef2f1db84f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Tretinoin
154 rdf:type schema:DefinedTerm
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
159 schema:name Pharmacology and Pharmaceutical Sciences
160 rdf:type schema:DefinedTerm
161 sg:journal.1094644 schema:issn 0724-8741
162 1573-904X
163 schema:name Pharmaceutical Research
164 schema:publisher Springer Nature
165 rdf:type schema:Periodical
166 sg:person.01007744060.52 schema:affiliation grid-institutes:grid.62562.35
167 schema:familyName Carroll
168 schema:givenName F. Ivy
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007744060.52
170 rdf:type schema:Person
171 sg:person.011330011677.32 schema:affiliation grid-institutes:grid.62562.35
172 schema:familyName Black
173 schema:givenName Sherry L.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011330011677.32
175 rdf:type schema:Person
176 sg:person.01246547754.63 schema:affiliation grid-institutes:grid.419971.3
177 schema:familyName Nair
178 schema:givenName Xina
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246547754.63
180 rdf:type schema:Person
181 sg:person.01330234261.41 schema:affiliation grid-institutes:grid.419971.3
182 schema:familyName Bouquin
183 schema:givenName Pamela
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330234261.41
185 rdf:type schema:Person
186 sg:person.01354063200.10 schema:affiliation grid-institutes:grid.62562.35
187 schema:familyName Bos
188 schema:givenName Mary E.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354063200.10
190 rdf:type schema:Person
191 sg:person.01362776354.62 schema:affiliation grid-institutes:grid.419971.3
192 schema:familyName Tetrault
193 schema:givenName Geraldine
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362776354.62
195 rdf:type schema:Person
196 sg:person.0615103145.58 schema:affiliation grid-institutes:grid.62562.35
197 schema:familyName Lewin
198 schema:givenName Anita H.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615103145.58
200 rdf:type schema:Person
201 sg:person.0634600476.22 schema:affiliation grid-institutes:grid.62562.35
202 schema:familyName Goehring
203 schema:givenName R. Richard
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634600476.22
205 rdf:type schema:Person
206 sg:person.0753620654.00 schema:affiliation grid-institutes:grid.419971.3
207 schema:familyName Whiting
208 schema:givenName Gary
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753620654.00
210 rdf:type schema:Person
211 sg:pub.10.1023/a:1018938920796 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017325399
212 https://doi.org/10.1023/a:1018938920796
213 rdf:type schema:CreativeWork
214 sg:pub.10.1023/a:1018955925223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012524380
215 https://doi.org/10.1023/a:1018955925223
216 rdf:type schema:CreativeWork
217 grid-institutes:grid.419971.3 schema:alternateName Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York
218 schema:name Pharmaceutical Research and Development Division, Dermatology Research, Bristol-Myers Squibb Company, 14213, Buffalo, New York
219 rdf:type schema:Organization
220 grid-institutes:grid.62562.35 schema:alternateName Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina
221 schema:name Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, 27709, North, Carolina
222 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...